AGM
UTHR icon

Alpine Global Management’s United Therapeutics UTHR Stock Holding History

Alpine Global Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$909K Buy
+1,678
New +$945K 0.15% 72
2020
Q1 		– Sell
-5,389
Closed -$475K – 430
2019
Q4 		$475K Buy
+5,389
New +$474K 0.1% 167
2016
Q3 		– Sell
-2,467
Closed -$261K – 157
2016
Q2 		$261K Buy
+2,467
New +$275K 0.12% 81
2016
Q1 		– Sell
-3,966
Closed -$621K – 198
2015
Q4 		$621K Buy
+3,966
New +$577K 0.2% 66

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Alpine Global Management's UTHR Position: Q2 2026 in Review

Alpine Global Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,678 shares worth $909K. The stake represents 0.15% of the portfolio and ranks #72 among its holdings. This is a return to the name: Alpine Global Management previously reported a position in UTHR as recently as Q4 2019.

Alpine Global Management first reported a position in UTHR in Q4 2015 and has held it in 4 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Alpine Global Management held 1,678 shares of United Therapeutics worth $909K as of Q2 2026.
  • United Therapeutics was a new Alpine Global Management position in Q2 2026.
  • United Therapeutics made up 0.15% of Alpine Global Management's portfolio in Q2 2026, its #72 holding.
  • Alpine Global Management first reported a position in United Therapeutics in Q4 2015 and has held it in 4 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.